Teddi Mellencamp’s life is hanging in the balance as she battles an aggressive form of Stage 4 skin cancer. The “Real Housewives of Beverly Hills” star revealed this week that her dad ...

A Lesbury man made it to base camp of Mount Everest to raise funds for pancreatic cancer in memory of his grandad. Matteo Neri completed the 16-day Nepal trek, walking for around 12 hours a day ...

Pancreatic cancer is predicted to become the second-deadliest cancer in the US by 2030. Researchers at the Cold Spring Harbor Laboratory have found a way to slow the progression of pancreatic ...

Dr. Tom Sellers had been in the role for a little over a year. Dr. Tom Sellers, who has served as director of the OHSU Knight Cancer Institute for the past year, has resigned. Sellers took the ...

"Lung cancer has not traditionally been thought of as a dietary-related disease," says Sun. "Diseases like pancreatic cancer or liver cancer, yes. However, when it comes to lung cancer, the idea that ...

The director of Oregon Health & Science University’s $1 billion Knight Cancer Institute resigned this week after just one year on the job, leaving OHSU with yet another interim leader in a key role.

When is the Hollow Knight Silksong release date? Silksong is the long-awaited sequel to 2017’s immensely popular Hollow Knight. We don’t use the phrase ‘long-awaited’ lightly either ...

Scientists have developed a new method for identifying and classifying pancreatic cancer cell subtypes based on sugars found on the outside of cancer cells. These sugars, called glycans ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, according to a new gastroenterology study. Pancreatic ductal adenocarcinoma (PDAC) is one of the ...

Over 90% of patients with metastatic pancreatic cancer achieved at least one indicator of guideline-concordant care. The percentage of patients achieving at least one quality indicator has ...

Disparities in mPDAC care quality and outcomes are linked to race and socioeconomic status, affecting cancer-specific survival. Socially vulnerable and minority patients are less likely to receive ...